Cargando…

Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study

BACKGROUND: High levels of fetal haemoglobin (HbF) decrease sickle cell anaemia (SCA) severity and leads to improved survival. According to in vivo and in vitro studies, butyrate increases HbF production. Its utilization in clinical practice is hampered, however, by its short half-life. Serum butyra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaddam, Lamis, FdleAlmula, Imad, Eisawi, Omer Ali, Abdelrazig, Haydar Awad, Elnimeiri, Mustafa, Lang, Florian, Saeed, Amal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696138/
https://www.ncbi.nlm.nih.gov/pubmed/26719803
http://dx.doi.org/10.1186/s12878-015-0040-6
_version_ 1782407734905274368
author Kaddam, Lamis
FdleAlmula, Imad
Eisawi, Omer Ali
Abdelrazig, Haydar Awad
Elnimeiri, Mustafa
Lang, Florian
Saeed, Amal M.
author_facet Kaddam, Lamis
FdleAlmula, Imad
Eisawi, Omer Ali
Abdelrazig, Haydar Awad
Elnimeiri, Mustafa
Lang, Florian
Saeed, Amal M.
author_sort Kaddam, Lamis
collection PubMed
description BACKGROUND: High levels of fetal haemoglobin (HbF) decrease sickle cell anaemia (SCA) severity and leads to improved survival. According to in vivo and in vitro studies, butyrate increases HbF production. Its utilization in clinical practice is hampered, however, by its short half-life. Serum butyrate concentrations could be enhanced by colonic bacterial fermentation of Gum Arabic (GA), edible, dried, gummy exudates from Acacia Senegal tree. We hypothesized that regular intake of GA increases serum butyrate levels, thus inducing HbF production and ameliorating symptoms of sickle cell anemia. METHODS: Fourty seven patients (5–42 years) carrying hemoglobin SS were recruited from April 2014 to January 2015. Patients received 30 g/day GA for 12 weeks. HbF, blood count and erythropoietin level were measured. The main outcome of interest was the level of HbF after 12 weeks. The secondary outcomes were improvement in clinical and laboratory results. The study was ethically approved by Alneelain University IRB. RESULTS: The study revealed significant increase in HbF level P.V0.000 [95 % CI, 0.43–1.02], MCV P.V:000 [95 % CI, 2.312–6.058] and Hematocrit level P.V:0.026 [95 % CI, 0.124–1.902]. No significant difference was encountered in platelets count P.V: 0.346 [95 % CI,−25.76–71.94], and WBCs count P.V:0.194 [95 % CI,−8.035–1.68]. Thirty seven percent of patients experienced minor side effects which resolved within a week. CONCLUSION: These findings reveal a novel effect of GA, which may be used to foster fetal hemoglobin production. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02467257. Registered 3rd June 2015. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12878-015-0040-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4696138
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46961382015-12-31 Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study Kaddam, Lamis FdleAlmula, Imad Eisawi, Omer Ali Abdelrazig, Haydar Awad Elnimeiri, Mustafa Lang, Florian Saeed, Amal M. BMC Hematol Research Article BACKGROUND: High levels of fetal haemoglobin (HbF) decrease sickle cell anaemia (SCA) severity and leads to improved survival. According to in vivo and in vitro studies, butyrate increases HbF production. Its utilization in clinical practice is hampered, however, by its short half-life. Serum butyrate concentrations could be enhanced by colonic bacterial fermentation of Gum Arabic (GA), edible, dried, gummy exudates from Acacia Senegal tree. We hypothesized that regular intake of GA increases serum butyrate levels, thus inducing HbF production and ameliorating symptoms of sickle cell anemia. METHODS: Fourty seven patients (5–42 years) carrying hemoglobin SS were recruited from April 2014 to January 2015. Patients received 30 g/day GA for 12 weeks. HbF, blood count and erythropoietin level were measured. The main outcome of interest was the level of HbF after 12 weeks. The secondary outcomes were improvement in clinical and laboratory results. The study was ethically approved by Alneelain University IRB. RESULTS: The study revealed significant increase in HbF level P.V0.000 [95 % CI, 0.43–1.02], MCV P.V:000 [95 % CI, 2.312–6.058] and Hematocrit level P.V:0.026 [95 % CI, 0.124–1.902]. No significant difference was encountered in platelets count P.V: 0.346 [95 % CI,−25.76–71.94], and WBCs count P.V:0.194 [95 % CI,−8.035–1.68]. Thirty seven percent of patients experienced minor side effects which resolved within a week. CONCLUSION: These findings reveal a novel effect of GA, which may be used to foster fetal hemoglobin production. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02467257. Registered 3rd June 2015. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12878-015-0040-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-29 /pmc/articles/PMC4696138/ /pubmed/26719803 http://dx.doi.org/10.1186/s12878-015-0040-6 Text en © Kaddam et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kaddam, Lamis
FdleAlmula, Imad
Eisawi, Omer Ali
Abdelrazig, Haydar Awad
Elnimeiri, Mustafa
Lang, Florian
Saeed, Amal M.
Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
title Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
title_full Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
title_fullStr Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
title_full_unstemmed Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
title_short Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
title_sort gum arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696138/
https://www.ncbi.nlm.nih.gov/pubmed/26719803
http://dx.doi.org/10.1186/s12878-015-0040-6
work_keys_str_mv AT kaddamlamis gumarabicasfetalhemoglobininducingagentinsicklecellanemiainvivostudy
AT fdlealmulaimad gumarabicasfetalhemoglobininducingagentinsicklecellanemiainvivostudy
AT eisawiomerali gumarabicasfetalhemoglobininducingagentinsicklecellanemiainvivostudy
AT abdelrazighaydarawad gumarabicasfetalhemoglobininducingagentinsicklecellanemiainvivostudy
AT elnimeirimustafa gumarabicasfetalhemoglobininducingagentinsicklecellanemiainvivostudy
AT langflorian gumarabicasfetalhemoglobininducingagentinsicklecellanemiainvivostudy
AT saeedamalm gumarabicasfetalhemoglobininducingagentinsicklecellanemiainvivostudy